Another thought- perhaps a muted response considering Astra...

Another thought- perhaps a muted response considering Astra Zeneca has 28 manufacturing sites across 16 countries. And the larger sites need up to two units. Fact we only got 5 might suggest some apprehension, OR they want to test how capable the rollout of an initial order is, after which they standardize it. Because 5 units is far from standardization - still a huge leg in the door. The real deal is standardization which would be 25 units+ or $20m revenue and that's just Astra Zeneca, let alone the two other large pharmas initiating their own validations with Lbt.